Michael Scolaro

Michael Scolaro

Nov 16, 2017

Group 6 Copy 173
0
    Please wait...

    About This Project

    We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Do Pacific Northwest marine mammals carry antibiotic-resistant bacteria from land animals?

    Antibiotic resistance, a global concern, is a significant health issue of animals and humans. Resistant bacteria...

    Does Antidepressant Use by Breastfeeding Mothers Lead to Autism?

    The aim of the current project is to investigate the consequences of developmental exposure to antidepressants...

    Can We Defeat EBOLA with an Experimental CANCER Drug?

    The Ebola outbreak in west Africa has been declared a global emergency by the WHO with over 1,000 victims and...

    Backer Badge Funded